Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEMAITRE VASCULAR INC Director's Dealing 2024

Mar 26, 2024

31708_dirs_2024-03-26_233de5fb-9e17-4dec-9ab7-6dd6457e5710.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2024-03-22

Reporting Person: LeMaitre George W (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-22 Common Stock M 7075 $47.19 Acquired 2194601 Direct
2024-03-22 Common Stock M 7733 $48.60 Acquired 2202334 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-22 Stock Option (Right to Buy) $48.60 M 7733 Disposed 2028-12-11 Common Stock (7733) Direct
2024-03-22 Stock Option (Right to Buy) $47.19 M 7075 Disposed 2029-12-12 Common Stock (7075) Direct

Footnotes

F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

F2: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the forth anniversary.